Data from multiple sources - Curated by Toby Galbraith - Last updated 04 January 2017

Latest news articles

Added 18 days ago Drug news

Phase III MISSION programme of two trials of elenbecestat are initiated by Eisai and Biogen for treatment of Alzheimers disease

Eisai Co., Ltd. announced that enrollment has commenced in Japan for MISSION AD1, a global Phase III clinical study of...

Added 1 month ago Drug news

MorphoSys AG announces Roche plans to initiate a Phase III programme with gantenerumab in patients with prodromal to mild Alzheimer's disease.

MorphoSys AG announced that its partner Roche plans to initiate a new pivotal phase III program for gantenerumab in patients...

Added 1 month ago Drug news

AC Immune SA + Genentech initiate a second Phase III trial for crenezumab to treat Alzheimers disease.

AC Immune SA announced that its partner Genentech, a member of Roche group, has decided to start a second Phase...

View all news articles

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

Visit Chronic Spontaneous Urticaria (CSU)

Psoriasis

See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more

Visit Psoriasis

Guidelines

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Alzheimer ’s disease and other dementias

Like with the preceding guidelines of this series (Bauer et al. 2002, Bandelow et al. 2008b), these practice guidelines for...

Added February 2011 ago

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

The British Association for Psychopharmacology (BAP) coordinated a meeting of experts to review and revise its first (2006) Guidelines for...

Added November 2010 ago

EFNS guidelines for the diagnosis and management of Alzheimer's disease

The aim of this revised international guideline was to present a peer-reviewed evidence-based statement for the guidance of practice for...

Added March 2010 ago

View all guidelines

Journal articles

Obesity and Structural Brain Integrity in Older Women: The Women's Health Initiative Magnetic Resonance Imaging Study.

Background: Midlife obesity has been linked to age-related brain atrophy and risk of dementia, but the relationships are less clear...

Added March 2016 ago

Insomnia and risk of dementia in older adults: Systematic review and meta-analysis.

There are cross-sectional evidences of an association between sleep disorders and cognitive impairment on older adults. However, there are no...

Added March 2016 ago

Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.

Introduction: As the most common major neurocognitive disorder, Alzheimer's disease (AD) will play an increasingly important role both socially and...

Added February 2016 ago

View all journal articles

Clinical trials

ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit

Intensive care unit (ICU) hospitalization saves lives but often does so at a high personal cost to ICU survivors who frequently experience significant cognitive impairment and an array of physical and functional...

Added February 2011 ago

View all clinical trials
Dr Sarah Brewer

Dr Sarah Brewer MSc (Nutr Med), MA (Cantab), MB, BChir, RNutr, MBANT, CNHC qualified from Cambridge University with degrees in Natural Sciences, Medicine and Surgery. After working in general practice, she gained a Master's degree in Nutritional Medicine from the University of Surrey. ... Read more

Can Diet Reduce The Risk Of Alzheimer's Dementia?

Wouldn't it be great if we could recommend evidence-based, nutritional approaches to help prevent Alzheimer's dementia? Or to slow the progression of cognitive decline in those already living with an Alzheimer's diagnosis? Two recent papers suggest we can do just that.

CME

Diabetes care, antivirals for flu and dementia risk: update clinical February 2016

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Hallucinations - red flag symptoms

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Alzheimer's disease: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0
View all CME